Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. XENE
XENE logo

XENE News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

XENE News

Octagon Capital Acquires Stake in Xenon Pharmaceuticals

May 18 2026Fool

Xenon Pharmaceuticals Q1 2026 Earnings Call Highlights

May 08 2026seekingalpha

Xenon Pharmaceuticals Q1 Earnings Beat Expectations

May 07 2026seekingalpha

AAN Meeting: Azetukalner Significantly Reduces Seizure Frequency in Epilepsy

Apr 19 2026Newsfilter

Xenon Pharmaceuticals Reports Significant Efficacy of Azetukalner in Epilepsy Studies

Apr 19 2026Yahoo Finance

Xenon Pharmaceuticals to Present at Four Investor Conferences

Apr 15 2026Newsfilter

Xenon Pharmaceuticals Presents New Drug Study Results at AAN Meeting

Apr 07 2026Newsfilter

Xenon Pharmaceuticals CMO Sells Shares Amid RSU Vesting

Mar 27 2026Fool

XENE Events

No data

No data

XENE Monitor News

Xenon Pharmaceuticals to Announce Phase 3 Data for Azetukalner

Mar 09 2026

XENE Earnings Analysis

No Data

No Data

People Also Watch